July 16, 2026
Dear Chair Cassidy, Chair Crapo, Chair Guthrie, and Chair Comer:
On behalf of the thousands of physicians and medical professionals we represent, AAPLOG (the American Association of Pro-Life Obstetricians and Gynecologists) writes to share the results of a recent investigation we conducted into the online ordering and mail distribution of mifepristone. The findings raise significant concerns regarding patient safety, informed consent, and the lack of medical oversight in the online distribution of abortion pills.
Alarmingly, our investigation found many risks patients may not realize when accessing these drugs through online providers:
- No identity requirements or age verification during the ordering process
- No direct interaction with a physician
- Inadequate screening for medical risks or contraindications
- The ability for minors and even abusers to obtain the pills online
What this investigation uncovered is far from anything that could be called healthcare. In fact, it should be considered medical malpractice. The FDA removed patient safeguards during the Covid-19 pandemic, removing in-person dispensing requirements that had been in place for two decades. Yet this mail-order process for abortion pills remains in use with complete disregard for patient safety.